fda update on tirzepatide approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Compounded Semaglutide & Tirzepatide 2025:

Such enhancements simplify laboratory procedures and extend peptide shelf life under controlled conditions

Youve heard of Ozempic butt, Ozempic fingers, Ozempic mouth and Ozempic teeth now, theres a new term to add to the GLP-1 lexicon: Ozempic breath. Bad breath is a common side effect of GLP-1 diabetes and weight loss drugs like Ozempic because they slow digestion, causing food to linger and ferment in the stomach

Doctors have used this class of medication to treat Type 2 diabetes for more than 10 years

No representation is made or implied that the blend or any of its four components is fit for human or veterinary administration

Semaglutide does just that by taking a cue from the GLP-1 hormone, a natural regulator in our bodies that tells us when weve eaten enough

For those unfamiliar with my work on obesity, heres the context necessary to understand this issue, and how it relates to the GLP-1 drugs